MEI Pharma Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible Digital Asset and Cash Borrowing

Reuters09-05

<a href="https://laohu8.com/S/MEIP">MEI Pharma</a> Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible <a href="https://laohu8.com/S/DAAQU">Digital Asset</a> and Cash Borrowing

MEI Pharma Inc. has entered into a new master loan agreement with BitGo Prime, LLC, as announced on September 3, 2025. This agreement establishes a framework allowing MEI Pharma to borrow digital assets or cash from BitGo Prime. Each loan will be documented with specific terms such as principal amount, fees, collateral requirements, and maturity date. The interest rate, or loan fee, will be determined for each loan and calculated daily at an annualized rate as specified in each confirmation. The agreement includes provisions for fixed terms, call options, or prepayment options, along with standard collateral and default terms. This arrangement aims to provide MEI Pharma with flexible financing options for its operational needs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000929638-25-003398), on September 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2565558836?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-05 04:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2565558836","market":"fut","top_or_hot":-1,"title":"MEI Pharma Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible Digital Asset and Cash Borrowing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/MEIP\">MEI Pharma</a> Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible <a href=\"https://laohu8.com/S/DAAQU\">Digital Asset</a> and Cash Borrowing\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MEI Pharma Inc. has entered into a new master loan agreement with BitGo Prime, LLC, as announced on September 3, 2025. This agreement establishes a framework allowing MEI Pharma to borrow digital assets or cash from BitGo Prime. Each loan will be documented with specific terms such as principal amount, fees, collateral requirements, and maturity date. The interest rate, or loan fee, will be determined for each loan and calculated daily at an annualized rate as specified in each confirmation. The agreement includes provisions for fixed terms, call options, or prepayment options, along with standard collateral and default terms. This arrangement aims to provide MEI Pharma with flexible financing options for its operational needs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000929638-25-003398), on September 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEI Pharma Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible Digital Asset and Cash Borrowing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEI Pharma Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible Digital Asset and Cash Borrowing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-05 04:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/MEIP\">MEI Pharma</a> Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible <a href=\"https://laohu8.com/S/DAAQU\">Digital Asset</a> and Cash Borrowing\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MEI Pharma Inc. has entered into a new master loan agreement with BitGo Prime, LLC, as announced on September 3, 2025. This agreement establishes a framework allowing MEI Pharma to borrow digital assets or cash from BitGo Prime. Each loan will be documented with specific terms such as principal amount, fees, collateral requirements, and maturity date. The interest rate, or loan fee, will be determined for each loan and calculated daily at an annualized rate as specified in each confirmation. The agreement includes provisions for fixed terms, call options, or prepayment options, along with standard collateral and default terms. This arrangement aims to provide MEI Pharma with flexible financing options for its operational needs.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000929638-25-003398), on September 04, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LITS","symbol_name":"Lite Strategy Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL53PQsn:1","article_id":"2565558836","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2565558836","pubTimestamp":1757017916,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"MEI Pharma Inc. has entered into a new master loan agreement with BitGo Prime, LLC, as announced on September 3, 2025. This agreement establishes a framework allowing MEI Pharma to borrow digital assets or cash from BitGo Prime. Each loan will be documented with specific terms such as principal amount, fees, collateral requirements, and maturity date. The interest rate, or loan fee, will be determined for each loan and calculated daily at an annualized rate as specified in each confirmation. The agreement includes provisions for fixed terms, call options, or prepayment options, along with standard collateral and default terms. This arrangement aims to provide MEI Pharma with flexible financing options for its operational needs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LITS":"Lite Strategy Inc.","BK4139":"生物科技"},"translate_title":"MEI Pharma Inc.与BitGo Prime，LLC签订新的主贷款协议，以实现灵活的数字资产和现金借贷","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEIP":0.9,"LITS":0.9},"content_text":"MEI Pharma Inc. Enters New Master Loan Agreement with BitGo Prime, LLC for Flexible Digital Asset and Cash Borrowing\n    \n\n        MEI Pharma Inc. has entered into a new master loan agreement with BitGo Prime, LLC, as announced on September 3, 2025. This agreement establishes a framework allowing MEI Pharma to borrow digital assets or cash from BitGo Prime. Each loan will be documented with specific terms such as principal amount, fees, collateral requirements, and maturity date. The interest rate, or loan fee, will be determined for each loan and calculated daily at an annualized rate as specified in each confirmation. The agreement includes provisions for fixed terms, call options, or prepayment options, along with standard collateral and default terms. This arrangement aims to provide MEI Pharma with flexible financing options for its operational needs.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000929638-25-003398), on September 04, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2565558836","isCrawlerRequest":true}